Epidemiology of Acute Otomastoiditis in Pediatric Age
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 8, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a condition called acute otomastoiditis, which is an infection that affects the ear and nearby areas, particularly in children. The goal of the study is to gather information about how common this condition is and to develop better guidelines for diagnosing and treating it. By doing this, the researchers hope to reduce the time it takes to diagnose the condition and improve treatment outcomes for young patients. They will also look at different treatment options and identify any factors that might lead to complications.
To participate in this trial, children aged 14 years or younger who have been diagnosed with acute otomastoiditis can be included. There are no specific exclusions mentioned, so if your child fits this age range and has the diagnosis, they may be eligible. Participants can expect to receive care related to their condition, and their experience will help inform better practices for future patients. This study is currently recruiting, which means they are looking for children to join and contribute to this important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged ≤14 years with an established diagnosis of acute otomastoiditis
- Exclusion Criteria:
- • NA
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Luca Pierantoni, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported